blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3495355

EP3495355 - LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCER [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  04.11.2022
Database last updated on 05.10.2024
FormerRequest for examination was made
Status updated on  10.05.2019
Most recent event   Tooltip04.11.2022Withdrawal of applicationpublished on 07.12.2022  [2022/49]
Applicant(s)For all designated states
Deutsches Krebsforschungszentrum
Im Neuenheimer Feld 280
69120 Heidelberg / DE
For all designated states
Ruprecht-Karls-Universität Heidelberg
Grabengasse 1
69117 Heidelberg / DE
[2019/24]
Inventor(s)01 / Eder, Matthias
Seckenheimer Hauptstr. 95
68239 Mannheim / DE
02 / Kopka, Klaus
Hauptstr. 60a
69221 Dossenheim / DE
03 / Schäfer, Martin
Am Pfaffenrain 19
69239 Neckarsteinach / DE
04 / Bauder-Wüst, Ulrike
Im Klingen 7
69198 Schriesheim / DE
05 / Haberkorn, Uwe
Königsäcker 82
68723 Schwetzingen / DE
06 / Eisenhut, Michael
Schloss Wolfsbrunnenweg 33a
69118 Heidelberg / DE
07 / Benesova, Martina
Am Paffenrain 19
69239 Neckarsteinach / DE
08 / Mier, Walter
Brückenweg 21
64625 Bensheim / DE
 [2019/24]
Representative(s)Kilger, Ute
Boehmert & Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22
80336 München / DE
[2019/24]
Application number, filing date18203547.717.10.2014
[2019/24]
Priority number, dateEP2013000499118.10.2013         Original published format: EP 13004991
EP2014017561203.07.2014         Original published format: EP 14175612
[2019/24]
Previously filed application, dateWO2014EP0280817.10.2014
[2019/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3495355
Date:12.06.2019
Language:EN
[2019/24]
Search report(s)(Supplementary) European search report - dispatched on:EP04.04.2019
ClassificationIPC:C07D295/145, C07B59/00, A61K51/04, A61P35/00, C07D257/02
[2019/24]
CPC:
A61K51/0402 (EP,IL,US); C07D295/145 (EP,IL,KR,US); A61K51/0482 (IL,US);
A61K51/04 (IL,KR); A61K51/044 (IL,KR); A61K51/0497 (EP,IL,US);
A61P13/08 (EP,IL); A61P35/00 (EP,IL); A61P35/04 (EP,IL);
C07B59/002 (EP,IL,KR,US); C07D257/02 (EP,IL,US); G01N33/574 (IL,KR);
G01N33/60 (IL,KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/24]
Extension statesBA30.10.2018
TitleGerman:MARKIERTE INHIBITOREN DES PROSTATASPEZIFISCHEN MEMBRANANTIGENS (PSMA), DEREN VERWENDUNG ALS KONTRASTMITTEL UND PHARMAZEUTIKA ZUR BEHANDLUNG VON PROSTATAKREBS[2019/24]
English:LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), THEIR USE AS IMAGING AGENTS AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PROSTATE CANCER[2019/24]
French:INHIBITEURS MARQUÉS DE L'ANTIGÈNE MEMBRANAIRE SPÉCIFIQUE DE LA PROSTATE (PSMA), LEUR UTILISATION COMME AGENTS D'IMAGERIE ET AGENTS PHARMACEUTIQUES POUR LE TRAITEMENT DU CANCER DE LA PROSTATE[2019/24]
Examination procedure30.10.2018Examination requested  [2019/24]
31.10.2022Application withdrawn by applicant  [2022/49]
Parent application(s)   TooltipEP14799340.6  / EP3038996
Fees paidRenewal fee
30.10.2018Renewal fee patent year 03
30.10.2018Renewal fee patent year 04
30.10.2018Renewal fee patent year 05
28.10.2019Renewal fee patent year 06
27.10.2020Renewal fee patent year 07
27.10.2021Renewal fee patent year 08
27.10.2022Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Stay/Interruption27.11.2018Stay of proceedings[2019/30]
27.11.2018Stay of proceedings[2022/13]
02.05.2022Resumption of proceedings[2022/13]
Documents cited:Search[AD]WO2013022797  (MOLECULAR INSIGHT PHARM INC [US], et al);
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.